Australian Care Magic Hirudin Peptid Pellet
NDC Package 85119-001-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Australian Care Magic Hirudin Peptid pellets is take 1-2 Tablet(s) daily with meal. This formulation utilizes a pellet delivery system. Marketed by Lacues Pty Ltd, this product is identified by NDC 85119-001 and is authorized under FDA application 505G(a)(3).

Identification & Billing

NDC Package Code
85119-001-01
Package Description
72000 mg in 1 BOTTLE
Product Code
11-Digit Billing Format
85119000101

Clinical Specifications

Proprietary Name
Australian Care Magic Hirudin Peptid
Non-Proprietary Name
Australian Care Magic Hirudin Peptid
Substance Name
Hirudin
Dosage Form
Pellet - A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Take 1-2 Tablet(s) daily with meal

Regulatory & Marketing

Labeler Name
Lacues Pty Ltd
Product Type
Human Otc Drug
FDA Application #
505G(a)(3)
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
01-10-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 85119-001-01 identifies a specific commercial package of 72000 mg in 1 bottle of Australian Care Magic Hirudin Peptid, a human over the counter drug labeled by Lacues Pty Ltd. This pellet is formulated for oral use and contains hirudin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Lacues Pty Ltd on January 10, 2025. The current certification is valid through December 31, 2026.

How is this Lacues Pty Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 85119000101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
85119-001-01
11-Digit CMS (5-4-2)
85119-0001-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.